ImageneBio Inc (IMA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 122.01M | 140.29M | 147.53M | 99.01M | 117M | 127.17M | 141.53M | 149.32M | 161.17M | 178.66M | 200.63M | 160.65M |
| Cash & Short-Term Investments | 117.21M | 75.78M | 142.58M | 95.64M | 114.05M | 124.39M | 138.03M | 145.42M | 157.35M | 175.47M | 196.93M | 157.31M |
| Cash Only | 76.05M | 34.97M | 103.16M | 58.29M | 36.76M | 39.39M | 45.19M | 44.27M | 52.85M | 119.89M | 121.28M | 70.87M |
| Short-Term Investments | 41.16M | 40.82M | 39.42M | 37.35M | 77.29M | 84.99M | 92.84M | 101.15M | 104.5M | 55.57M | 75.66M | 86.44M |
| Accounts Receivable | 0 | 1.3M | 728K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.8M | 59.56M | 0 | 3.37M | 2.95M | 2.78M | 3.5M | 3.9M | 400K | 1.15M | 1.02M | 731K |
| Total Non-Current Assets | 14.68M | 12.69M | 13.35M | 27.15M | 13.84M | 14.34M | 7.46M | 8.16M | 11.62M | 13.43M | 14.7M | 11.12M |
| Property, Plant & Equipment | 616K | 0 | 885K | 2.98M | 3.61M | 4.23M | 4.84M | 5.55M | 6.11M | 8.02M | 10.63M | 7.45M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.07x | 0.13x | 0.26x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 7.51M | 0 | 0 | 0 | 872K | 1.28M | 0 | 0 | 1.28M | 0 |
| Other Non-Current Assets | 14.06M | 12.69M | 4.95M | 24.17M | 10.23M | 10.11M | 1.74M | 1.33M | 5.51M | 5.41M | 2.8M | 3.67M |
| Total Assets | 136.68M | 152.98M | 160.88M | 126.17M | 130.84M | 141.51M | 148.99M | 157.49M | 172.78M | 192.09M | 215.34M | 171.76M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x | 0.01x | 0.01x |
| Asset Growth % | 4.47% | 8.1% | 7.98% | -19.89% | -24.28% | -26.33% | -30.81% | -8.31% | 13.37% | 11.51% | 13.06% | -18.67% |
| Total Current Liabilities | 6.63M | 11.23M | 11.14M | 7.32M | 8.79M | 10.78M | 9.24M | 8.2M | 10.17M | 14.21M | 19.27M | 12.01M |
| Accounts Payable | 568K | 1.44M | 2.08M | 512K | 805K | 897K | 1.54M | 1.41M | 1.91M | 2.07M | 3.95M | 1.77M |
| Days Payables Outstanding | 519.05 | 288.63 | - | 1.33K | 20.62 | 24.48 | 19.89 | 377.31 | 18.75 | 907.33 | 1.09K | 14.53 |
| Short-Term Debt | 2.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.47M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 659K | 1.84M |
| Other Current Liabilities | 3.76M | 7.53M | 4.91M | 522K | 447K | 1.75M | 3.78M | 1.7M | 46K | 3.4M | 8.23M | 1.94M |
| Current Ratio | 18.39x | 12.49x | 13.24x | 13.52x | 13.31x | 11.80x | 15.32x | 18.22x | 15.85x | 12.58x | 10.41x | 13.38x |
| Quick Ratio | 18.39x | 12.49x | 13.24x | 13.52x | 13.31x | 11.80x | 15.32x | 18.22x | 15.85x | 12.58x | 10.41x | 13.38x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 6.72M | 8.6M | 9.9M | 2.94M | 3.79M | 4.8M | 5.52M | 6.43M | 7.27M | 8.13M | 8.88M | 3.06M |
| Long-Term Debt | 5.73M | 7.02M | 7.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 110K | 713K | 1.28M | 1.84M | 2.72M | 3.74M | 4.47M | 5.4M | 6.3M | 7.18M | 8.02M | 3.06M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 881K | 870K | 1.06M | 1.09M | 1.08M | 1.06M | 1.04M | 1.03M | 964K | 950K | 852K | 0 |
| Total Liabilities | 13.36M | 19.84M | 21.05M | 10.26M | 12.59M | 15.58M | 14.76M | 14.63M | 17.43M | 22.34M | 28.15M | 15.06M |
| Total Debt | 8.15M | 9.99M | 10.96M | 5.68M | 6.61M | 7.52M | 8.39M | 9.09M | 9.74M | 10.74M | 11.49M | 4.99M |
| Net Debt | -67.9M | -24.97M | -92.21M | -52.61M | -30.15M | -31.87M | -36.8M | -35.18M | -43.11M | -109.16M | -109.78M | -65.88M |
| Debt / Equity | 0.07x | 0.08x | 0.08x | 0.05x | 0.06x | 0.06x | 0.06x | 0.06x | 0.06x | 0.06x | 0.06x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -257.89x | - | - | - | - | - | - | -16.90x | - | - |
| Total Equity | 123.33M | 133.14M | 139.83M | 115.91M | 118.25M | 125.93M | 134.23M | 142.86M | 155.35M | 169.76M | 187.19M | 156.7M |
| Equity Growth % | 4.29% | 5.72% | 4.17% | -18.87% | -23.88% | -25.82% | -28.29% | -8.83% | 15.05% | 15.51% | 17.89% | -10.13% |
| Book Value per Share | 11.00 | 11.91 | 16.40 | 2.40 | 2.45 | 2.61 | 2.78 | 2.96 | 3.22 | 3.55 | 4.31 | 3.61 |
| Total Shareholders' Equity | 123.33M | 133.14M | 139.83M | 115.91M | 118.25M | 125.93M | 134.23M | 142.86M | 155.35M | 169.76M | 187.19M | 156.7M |
| Common Stock | 11K | 11K | 11K | 48K | 48K | 48K | 48K | 48K | 48K | 48K | 44K | 42K |
| Retained Earnings | -240.67M | -230.05M | -223.14M | -343M | -340.24M | -331.62M | -322.5M | -312.26M | -298.53M | -282.38M | -262.9M | -245.55M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -17K | 87K | 94K | 65K | 99K | 68K | 240K | -350K | -313K | -48K | -290K | -456K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |